Owlet, Inc.
NYSE:OWLTMedical - Devices
+$0.46 today
- Market cap
- $107.24M
- Beta
- 1.86
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$12.67
Volume 0.64M
Average 0.24M
OWLT Total Current Liabilities
All obligations due within one year.
Owlet, Inc.NYSE: OWLT
Total Current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total current liabilities rises 18.3% from a year ago
Total current liabilities stood at $48.14M at the end of Q1 FY2026, up 18.3% from a year earlier and up 8.9% from the prior quarter. Over 3 fiscal years it compounded at -12.8% a year.
Context
- Total current liabilities amounted to 55.5% of total assets at the end of Q1 FY2026, down 23.7 pp from a year earlier.
- Total current liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total current liabilities keeps rising in the next quarterly balance sheet after a +18.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 44.2M USD
- Year-over-year change
- +21.3%
- 4-year CAGR
- -10.6%
| Period | Period end | Total Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 44.2M | +21.3% |
| FY2024 | 2024-12-31 | 36.43M | -19.2% |
| FY2023 | 2023-12-31 | 45.09M | -32.3% |
| FY2022 | 2022-12-31 | 66.6M | -3.6% |
| FY2021 | 2021-12-31 | 69.09M | — |
Total Current Liabilities vs competitors
How OWLT compares with its peers on the latest reported figures
- OWLT's Mar 2026 total current liabilities of $48.14M is the highest of the 10 companies compared; the peer median is $17.8M.
- Its year-over-year change of +18.3% is the 3rd highest of 10, against a peer median of -5.1%.
- Total current liabilities amounts to 55.5% of total assets for OWLT, versus a peer median of 26.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $48.14M | +18.3% | -12.8% | 55.5% | |
| Mar 2026 | $29.39M | -19.6% | +50.3% | 86.2% | |
| Mar 2026 | $20.97M | +17.1% | -7.8% | 11.7% | |
| Mar 2026 | $19.12M | +27.5% | -1.0% | 30.7% | |
| Mar 2026 | $18.14M | +56.1% | +17.9% | 12.6% | |
| Mar 2026 | $17.8M | -34.5% | +52.6% | 26.9% | |
| Mar 2026 | $14.46M | +8.8% | +28.1% | 29.4% | |
AVRAnteris Technologies Global Corp. | Mar 2026 | $13.69M | -5.1% | +52.3% | 4.6% |
| Mar 2026 | $10.21M | -19.8% | -2.6% | 5.3% | |
ELTXElicio Therapeutics, Inc. | Mar 2026 | $7.23M | -36.7% | +5.7% | 31.9% |
| Peer median (excluding OWLT) | $17.8M | -5.1% | +17.9% | 26.9% | |
Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 95.05M | 11.23M | 16.56M | 20.25M | 35.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 10.47M | 15.96M | 13.97M | 12.14M | 22.9M |
| Inventory | 17.98M | 18.52M | 6.49M | 10.52M | 15.3M |
| Other Current Assets | 0 | 0 | 1 | 386K | 8.2M |
| Total Current Assets | 135.82M | 51.26M | 39.94M | 46.11M | 81.9M |
| Property, Plant & Equipment (Net) | 1.87M | 3.37M | 1.31M | 240K | 400K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.7M | 2.28M | 2.21M | 975K | 1.4M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 666K | 1.2M | 655K | 2.19M | 1.9M |
| Total Non-current Assets | 4.23M | 6.84M | 4.18M | 3.4M | 3.7M |
| Total Assets | 140.05M | 58.1M | 44.12M | 49.52M | 85.6M |
| Account Payables | 27.77M | 30.43M | 13.68M | 11.28M | 12M |
| Short-term Debt | 8.53M | 15.04M | 15.19M | 7.37M | 10.57M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 1.06M | 0 | 0 | 0 | 2.3M |
| Other Current Liabilities | 0 | 8.62M | 4.09M | 2.31M | (94K) |
| Total Current Liabilities | 69.09M | 66.6M | 45.09M | 36.43M | 44.2M |
| Long-term Debt | 7.99M | 0 | 0 | 4.33M | 2.46M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 7.77M | 975K | 28.69M | 29.82M | 3.47M |
| Total Non-current Liabilities | 15.77M | 2.14M | 28.71M | 34.23M | 5.93M |
| Total Liabilities | 84.86M | 68.74M | 73.8M | 70.66M | 50.2M |
| Common Stock | 11K | 1K | 1K | 2K | 3K |
| Retained Earnings | (143.42M) | (222.76M) | (255.66M) | (268.2M) | (307.87M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 55.19M | (10.64M) | (29.68M) | (21.15M) | 35.4M |
| Total Debt | 16.53M | 18.31M | 16.39M | 11.87M | 13.03M |
| Net Debt | (78.53M) | 7.07M | (172K) | (8.38M) | (22.47M) |
Owlet, Inc.
NYSE:OWLT
Intrinsic Alpha fair value
Locked
Current Price
$3.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.